Germany· DE-A57-d4db4c00741dba35
Memantin Aristo
A memantine product containing memantine hydrochloride, registered in Germany by Aristo Pharma Gmbh (Art 57). The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Memantine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06DX01 (memantine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Memantine · ATC N06DX01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of memantine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.22 in United States to $2.93 in Spain — a ×13 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Memantine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- ES Spain$2.93
- CH Switzerland$2.47
- IT Italy$0.77
- US United States$0.22 (acquisition cost)
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Memantine Hydrochloride
- Manufacturer
- Aristo Pharma Gmbh (Art 57)
- Country
- Germany (DE)
- ATC code
- N06DX01
- ATC class
- Memantine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
139 interactions on record for memantine.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Memantine · interactions on record
139 records
- 42 moderate
- 11 minor
- 80 info
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
6 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Memantine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAXURAMerz Pharmaceuticals GmbH, Frankfurt am Main
- United StatesmemantineChartwell RX, LLC
- SpainALSEMORA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGGrindeks As
- United KingdomAlzhok 10mg soluble tabletsGlenmark Pharmaceuticals Europe Ltd
- PolandAuroMemoAurovitas Pharma Polska Sp. z o.o.
- NetherlandsAlsemora 10 mg filmomhulde tablettenGrindeks AS
- FinlandAdaxor AloituspakkausAvansor Pharma Oy
- BelgiumAlsemora 10 mgGrindeks
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Alsemora, Memantin 1a Pharma
- Belgium · Alsemora, Memantine Eg
- Bulgaria · Memantine Grindeks, Имана
- Cyprus · Alzedem, Mantomed
- Czechia · Cognomem, Mantomed
- Denmark · Alsemora, Marbodin
- Estonia · Alsemora, Mantomed
- Spain · Alsemora, Mantinex
- Finland · Alsemora, Marbodin
- France · Alsemora, Memantine Arrow Lab
- United Kingdom (Northern Ireland) · Memantine, Memantine Dawa
- Greece · Almerzac, Alsemora
- Croatia · Alsemora, Mantomed
- Hungary · Memantin Goodwill, Memantin Stada
- Ireland · Memantine Clonmel, Memantine Grindeks
- Iceland · Axura, Ebixa
- Italy · Demenco, Ezemantis
- Liechtenstein · Axura, Memantine Accord
- Lithuania · Alsemora, Maryzola
- Luxembourg · Memantine Eg
- Latvia · Alsemora, Mantomed
- Malta · Memantine Aurobindo, Memantine Clonmel
- Netherlands · Alsemora, Mantomed
- Norway · Alsemora, Axura
- Poland · Auromemo, Biomentin
- Portugal · Alsemora, Mantinex
- Romania · Alsemora, Memantina Atb
- Sweden · Alsemora, Marbodin
- Slovenia · Alsemora, Mantomed
- Slovakia · Alsemora, Mantomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afa3555e-4739-4cd5-be5d-73eeb4efd07f GET /v1/drugs/afa3555e-4739-4cd5-be5d-73eeb4efd07f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Memantine Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about memantine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.